Peter Szlosarek
Barts and The London NHS Trust
John Vane Science Centre
Charterhouse Square
London
EC1M 6BQ
United Kingdom
Email: peter.szlosarek@bartsandthelondon.nhs.uk
Tel: 0044-203-465-5046
Web: Lab website
Scientific summary
Dr Szlosarek is exploring why ASS1, a rate-limiting enzyme in L-arginine synthesis, is abnormally expressed in human cancers. Of therapeutic importance, ASS1-negative tumours are sensitive to L-arginine depletion and his group has been awarded a CTAAC grant to test this …
Peter Szlosarek other research projects
Phase III Clinical Trial Grants
Funding period: 01 December 2009 to 30 November 2012
Clinician Scientist Fellowship
Funding period: 01 January 2008 to 31 December 2012
Funding period: 01 December 2009 to 30 November 2012
Clinician Scientist Fellowship
Funding period: 01 January 2008 to 31 December 2012
Recent publications
Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
Br J Cancer.2008;98 :1452-1456
Increase text
Decrease text
Print this page